[The clinical efficacy of autofibronectin obtained by heparin cryoprecipitation in patients with trophic skin lesions].

The authors studied the clinical efficacy of the local external use of fibronectin obtained from autoplasma by heparin cryoprecipitation in 8 patients with immune complex pathology, paraproteinemic hemoblastoses and beta-thalassemia complicated by erosive and ulcerous skin lesions. Autofibronectin was shown to bring about complete healing of ulcerous defects within 10 to 45 days. The therapeutic approach suggested is money-saving and excludes a possibility of transmitting hepatitis B and immunodeficiency viruses by the patient.